| Germ line DDX41 mutations define a unique subtype of myeloid neoplasms H Makishima, R Saiki, Y Nannya, S Korotev, C Gurnari, J Takeda, ... Blood 141 (5), 534-549, 2023 | 112 | 2023 |
| The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood A Bertaina, L Vinti, L Strocchio, S Gaspari, R Caruso, M Algeri, V Coletti, ... British journal of haematology 176 (4), 629-636, 2017 | 87 | 2017 |
| Vacuolization of hematopoietic precursors: an enigma with multiple etiologies C Gurnari, S Pagliuca, L Durkin, L Terkawi, H Awada, S Kongkiatkamon, ... Blood, The Journal of the American Society of Hematology 137 (26), 3685-3689, 2021 | 80 | 2021 |
| Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia TM Chlon, E Stepanchick, CE Hershberger, NJ Daniels, KM Hueneman, ... Cell Stem Cell 28 (11), 1966-1981. e6, 2021 | 74 | 2021 |
| Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia H Awada, A Durmaz, C Gurnari, A Kishtagari, M Meggendorfer, CM Kerr, ... Blood, The Journal of the American Society of Hematology 138 (19), 1885-1895, 2021 | 63 | 2021 |
| Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria C Gurnari, S Pagliuca, PH Prata, JE Galimard, LFB Catto, L Larcher, ... Journal of Clinical Oncology 41 (1), 132-142, 2023 | 61 | 2023 |
| How I manage acquired pure red cell aplasia in adults C Gurnari, JP Maciejewski Blood, The Journal of the American Society of Hematology 137 (15), 2001-2009, 2021 | 53 | 2021 |
| Demethylation and up-regulation of an oncogene after hypomethylating therapy YC Liu, J Kwon, E Fabiani, Z Xiao, YV Liu, MY Follo, J Liu, H Huang, ... New England Journal of Medicine 386 (21), 1998-2010, 2022 | 43 | 2022 |
| Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond S Pagliuca, C Gurnari, MT Rubio, V Visconte, TL Lenz Frontiers in Immunology 13, 944872, 2022 | 42 | 2022 |
| Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia J Huuhtanen, D Bhattacharya, T Lönnberg, M Kankainen, C Kerr, ... Nature Communications 13 (1), 1981, 2022 | 38 | 2022 |
| The emerging role of measurable residual disease detection in AML in morphologic remission F Buccisano, L Maurillo, GJ Schuurhuis, MI Del Principe, A Di Veroli, ... Seminars in hematology 56 (2), 125-130, 2019 | 37 | 2019 |
| The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders S Pagliuca, C Gurnari, H Awada, A Kishtagari, S Kongkiatkamon, ... Blood, The Journal of the American Society of Hematology 138 (26), 2781-2798, 2021 | 36 | 2021 |
| Essential thrombocythemia and acquired von Willebrand syndrome: the shadowlands between thrombosis and bleeding H Awada, MT Voso, P Guglielmelli, C Gurnari Cancers 12 (7), 1746, 2020 | 31 | 2020 |
| The role of forkhead box proteins in acute myeloid leukemia C Gurnari, G Falconi, E De Bellis, MT Voso, E Fabiani Cancers 11 (6), 865, 2019 | 31 | 2019 |
| Update on VEXAS and role of allogeneic bone marrow transplant: considerations on behalf of the Chronic Malignancies Working Party of the EBMT C Gurnari, DP McLornan Bone Marrow Transplantation 57 (11), 1642-1648, 2022 | 30 | 2022 |
| UBA1 screening in sweet syndrome with hematological neoplasms reveals a novel association between VEXAS and chronic myelomonocytic leukemia C Gurnari, P Mannion, I Pandit, S Pagliuca, MT Voso, JP Maciejewski, ... Hemasphere 6 (10), e775, 2022 | 30 | 2022 |
| Congenital Rhabdomyosarcoma: a different clinical presentation in two cases I Russo, V Di Paolo, C Gurnari, A Mastronuzzi, F Del Bufalo, PL Di Paolo, ... Bmc Pediatrics 18, 1-5, 2018 | 30 | 2018 |
| Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML BQ Trinh, S Ummarino, Y Zhang, AK Ebralidze, MA Bassal, TM Nguyen, ... Blood, The Journal of the American Society of Hematology 138 (15), 1331-1344, 2021 | 29 | 2021 |
| When poisons cure: the case of arsenic in acute promyelocytic leukemia C Gurnari, E De Bellis, M Divona, T Ottone, S Lavorgna, MT Voso Chemotherapy 64 (5-6), 238-247, 2020 | 29 | 2020 |
| Development and validation of a prediction model of outcome after B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in relapsed/refractory multiple … N Gagelmann, D Dima, M Merz, H Hashmi, N Ahmed, N Tovar, ... Journal of Clinical Oncology 42 (14), 1665-1675, 2024 | 28 | 2024 |
